It will be interesting to determine whether non-neuroendocrine “inflammatory” tumor cells with restored ZFP36L1 emerge as a resistance mechanism to LSD1 inhibitors to evade SCLCs inherent neuroendocrine dependence. This evidence concerns the gene KDM1A and neoplasm.